Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y. Rolland
Observed names:
Rolland, Y.,
Rolland, Yann,
Y ROLLAND,
Y Rolland,
Yann Rolland
Institutions:
Inserm,
Laboratoire Traitement du Signal et de l'Image,
Université de Rennes
Observed institutions:
Inserm,
Laboratoire Traitement du Signal et de l'Image,
Centre Eugène Marquis,
Hôpital Pontchaillou,
Université de Rennes
OpenAlex ID:
A5109493863
Relevance of watermarking in medical imaging
2002
·
G. Coatrieux
, H. Maitre
, et al.
·
IEEE International Conference on Information Technology and Applications in Biomedicine
·
294
Comparison of automated and visual texture analysis in MRI: Characterization of normal and diseased skeletal muscle
1999
·
S. Herlidou
, Y. Rolland
, et al.
·
Magnetic Resonance Imaging
·
109
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
2012
·
Laurence Lenoir
, Julien Edeline
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
46
PDF
Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01).
2020
·
Etienne Garin
, Lambros Tzelikas
, et al.
·
Journal of Clinical Oncology
·
34
Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma
2009
·
J. Edeline
, B. Laguerre
, et al.
·
Annals of Oncology
·
25
[Aspects and value of MRI in the diagnosis and follow-up of common microbes infectious spondylodiscitis. Apropos of 25 clinically and biologically suspected patients].
1994
·
B De Korvin
, T Provensol
, et al.
·
PubMed
·
24
Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma
2003
·
E GARIN
, S LAFFONT
, et al.
·
Nuclear Medicine Communications
·
18
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patients
2026
·
Boris Guiu
, Clément Bailly
, et al.
·
EClinicalMedicine
·
10
Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis
2019
·
M. Pracht
, E. Chajon
, et al.
·
Annals of Oncology
·
7
PDF
Results from the phase I dose-escalation study of the radiation enhancer NBTXR3 for the treatment of HCC and liver metastases.
2021
·
Thierry De Baere
, Marc Pracht
, et al.
·
Journal of Clinical Oncology
·
5
A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis
2018
·
E. Chajon
, M. Pracht
, et al.
·
Annals of Oncology
·
5
Hafnium Oxide Nanoparticles Activated by SBRT for the Treatment of Hepatocellular Carcinoma and Liver Metastasis: A Phase I/II Trial
2019
·
E. Chajon Rodriguez
, M. Pracht
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
4
Tatouage d'images médicales : perception d'une marque
2003
·
Coatrieux, Gouenou
, Maître, Henri
, et al.
·
HAL
·
4
PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases
2020
·
T. De Baère
, M. Pracht
, et al.
·
Radiotherapy and Oncology
·
2
Toward a Deep Learning Prediction of the Biodistirbution of Radioactivity in Selective Internal Radiotherapy
2024
·
E. Morel Corlu
, A. Petit
, et al.
·
IEEE International Symposium on Biomedical Imaging (ISBI)
·
1
Phase I/II Study Of Radiation Enhancing Hafnium Oxide Nanoparticles NBTXR3 Activated by SBRT in HCC and Liver Metastases Patients
2020
·
T. De Baere
, M. Pracht
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Treatment of hepatocellular carcinoma and liver metastases with hafnium oxide nanoparticles activated by SBRT: A phase I/II trial.
2020
·
Nicolas Jaksic
, Marc Pracht
, et al.
·
Journal of Clinical Oncology
·
1
Hafnium Oxide Nanoparticles Activated By Radiotherapy: Potential for Local Treatment of a Wide Variety of Solid Tumors
2019
·
A.P. Dicker
, C. Shen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
OC-0281 Phase I/II trial of hafnium oxide nanoparticles activated by SBRT in the treatment of liver cancers
2019
·
E. Chajon
, M. Pracht
, et al.
·
Radiotherapy and Oncology
PDF
Effects of timing and number of SPECT acquisition on biodistribution and dose evaluation in hepatocellular carcinoma patients treated with Re-188 SSS Lipiodol radioembolization
2019
·
Delaunay, K.
, Garin, E.
, et al.
·
HAL
Hafnium Oxide Nanoparticles Activated By Radiation Therapy: An Innovative Approach for the Treatment of Liver Cancers
2018
·
E. Chajon Rodriguez
, M. Pracht
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Facteurs dosimétriques prédictifs de l’hypertrophie controlatérale après radioembolisation de lésions de CHC
2017
·
X. Palard
, J. Edeline
, et al.
·
Médecine Nucléaire
Factors influencing contralateral hypertrophy after lobar radioembolization for HCC
2017
·
E Garin
, Y Rolland
, et al.
·
Journal of Vascular and Interventional Radiology
PDF
High impact of tumor dose on response and overall survival for HCC patients treated with 90Y loaded glass microsphere radioembolization
2016
·
E. Garin
, Y. Rolland
, et al.
·
Journal of Vascular and Interventional Radiology
OP-02 Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: A new personalized promising concept
2013
·
E. Garin
, L. Lenoir
, et al.
·
Digestive and Liver Disease
PDF
Show more works
View as search
Works count:
30
Citation count:
591
H-index:
8
I10-index:
8
Year
Topic
Type